Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 12/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 1.00 |
| ▸ | SLC10A2 | Q12908 | 3/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 2/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 1/20 | 1.00 |
| ▸ | SLC10A1 | Q14973 | 6/20 | 0.89 |
| ▸ | VDR | P11473 | 1/20 | 0.79 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurochenodeoxycholate SCHEMBL9152921 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL4411471 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL13094131 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL12917602 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24001493 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL40763 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24435723 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17641266 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24015433 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17309129 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4853 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075501-A | Application of tauroursodeoxycholic acid in inhibiting alpha-glucosidase activity | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075500-A | Application of pig cholic acid bile acid component in preparation of medicine for treating irritable bowel syndrome | — | 2026-05-26 | — | — | CN | claimed |
| CN-122056828-A | Industrial preparation method of vitamin K1 micelle injection preparation | 浙江创新生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122017068-A | Bile acid high-flux detection method based on ultra-high performance liquid chromatography tandem mass spectrometry and application thereof | 青岛百谱生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005494-A | Lipid nanoparticle modified based on taurochenodeoxycholic acid and preparation method and application thereof | 福建普立辰生物技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122017071-A | Endogenous substance used as biomarker for alcohol-related liver diseases and control application thereof | 中国农业大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4721745-A1 | COMBINED PRODUCT, SALT AND USE THEREOF | Shanghai Henlius Biotech, Inc. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4721740-A1 | COMBINATION PRODUCT, SALT, AND USE THEREOF IN TREATING NEURODEGENERATIVE DISEASES OR DISORDERS | Shanghai Henlius Biotech, Inc. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-0435926-A1 | BILE ACIDS FOR TREATMENT OF VIRAL INFECTIONS | FISONS plc (GB) | 1991-07-10 | — | — | EP | claimed |
| US-5010056-A | Growth disorders | PIERREL SPA (IT) | 1991-04-23 | — | — | US | claimed |
| EP-0365139-A2 | Bile acids for the treatment of viral infections | FISONS plc (GB) | 1990-04-25 | — | — | EP | claimed |
| WO-1990003172-A2 | BILE ACIDS FOR TREATMENT OF VIRAL INFECTIONS | FISONS PLC (GB) | 1990-04-05 | — | — | WO | claimed |
| EP-0127535-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN | HADASSAH MEDICAL ORGANIZATION (IL) | 1990-01-03 | — | — | EP | claimed |
| EP-0301392-A1 | Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt | Pierrel S.p.A. (IT) | 1989-02-01 | — | — | EP | claimed |
| US-4579730-A | ORAL ADMINISTRATION; INSULIN BILE ACID OR SALT AND PROTEASE INHIBITOR | HADASSAH MEDICAL ORGANIZATION (IL) | 1986-04-01 | — | — | US | claimed |
| EP-0127535-A2 | Pharmaceutical compositions containing insulin | HADASSAH MEDICAL ORGANIZATION (IL) | 1984-12-05 | — | — | EP | claimed |
| US-4164573-A | INSULIN | GALINSKY ALVIN M | 1979-08-14 | — | — | US | claimed |
| US-4158707-A | Parenteral preparations | HOFFMANN-LA ROCHE INC. (US) | 1979-06-19 | — | — | US | claimed |